Published in Healthcare Finance, Tax and Law Weekly, February 14th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Endo Pharmaceuticals.
Report 1: Endo Pharmaceuticals Holdings Inc. (ENDP) announced the submission of a Citizen Petition with the U.S. Food and Drug Administration requesting that the FDA apply existing bioequivalence regulations to any Abbreviated New Drug Application (ANDA) seeking regulatory approval of a generic drug product that references Endo's Lidoderm (lidocaine topical patch 5%).
As disclosed on October 17, 2006, Endo became aware that, in response...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.